rhil-3 (PeproTech)
PeproTech is a verified supplier 
90
Structured Review
PeproTech
rhil-3
Rhil 3, supplied by PeproTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rhil-3/rhil+3/pmc12064758-243-35-36
Average 90 stars, based on 1 article reviews
Rhil 3, supplied by PeproTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rhil-3/rhil+3/pmc12064758-243-35-36
Average 90 stars, based on 1 article reviews
rhil-3 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Isolation:Article Title: 3-(5-methoxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof Article Snippet: Erythroid Differentiation Media is comprised of IMDM (Life Technologies) supplemented with insulin (10 μg/mL, Sigma Aldrich), heparin (2 U/mL Sigma Aldrich), holo-transferrin (330 μg/mL, Sigma Aldrich), human serum AB (5%, Sigma Aldrich), hydrocortisone (1 μM, STEMCELL Technologies), Article Title: Deciphering transcriptome alterations in bone marrow hematopoiesis at single-cell resolution in immune thrombocytopenia. Article Snippet: In vitro culture CD9+Lin−CD34+CD45RA− and CD9−Lin−CD34+CD45RA− HSPCs were cultured in 96-well plates with StemSpan SFEM II medium (09655, STEMCELL Technologies, Vancouver, BC, Canada) supplemented with recombinant human stem-cell factor (rhSCF; 50 ng/mL; PeproTech, Rocky Hill, NJ, USA), Article Title: Pyrazolopyridine derivatives and uses thereof Article Snippet: In the first phase, cells were cultured in StemSpanTM Serum-Free Expansion Media (SFEM) (STEMCELL Technologies Inc.) supplemented with Article Title: Large-scale discovery of potent, compact and erythroid specific enhancers for gene therapy vectors Article Snippet: Granulocytic/monocytic differentiation of CD34 + cells was achieved by culturing the cells in the same basal medium used for the ex vivo erythroid differentiation, with a different cytokine cocktail: 50 ng/mL Article Title: Deciphering transcriptome alterations in bone marrow hematopoiesis at single-cell resolution in immune thrombocytopenia Article Snippet: CD9 + Lin − CD34 + CD45RA − and CD9 − Lin − CD34 + CD45RA − HSPCs were cultured in 96-well plates with StemSpan SFEM II medium (09655, STEMCELL Technologies, Vancouver, BC, Canada) supplemented with recombinant human stem-cell factor (rhSCF; 50 ng/mL; PeproTech, Rocky Hill, NJ, USA), Article Title: Pyrazolopyridine derivatives and uses thereof Article Snippet: In the first phase, cells were cultured in StemSpanTM Serum-Free Expansion Media (SFEM) (STEMCELL Technologies Inc.) supplemented with Article Title: A hiPSC-derived lineage-specific vascular smooth muscle cell-on-a-chip identifies aortic heterogeneity across segments. Article Snippet: Aortic aneurysm (AA), a potentially lethal condition with the characteristic of aortic dilatation, can only be treated by surgical or endovascular procedures.. The underlying mechanisms of AA are unclear and early preventive treatment is still insufficient due to segmental aortic heterogeneity and the limitations of current disease models.. Here, we firstly established a comprehensive lineage-specific vascular smooth muscle cell (SMC)-on-a-chip model using human induced pluripotent stem cells to yield cell lineages representing different segments of the aorta and tested the constructed organ-on-a-chip model under various tensile stress conditions. Article Title: 3-(5-methoxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof Article Snippet: In the first phase, cells were cultured in STEMSPANTM Serum-Free Expansion Media (SFEM) (STEMCELL Technologies Inc.) supplemented with Cell Culture:Article Title: 3-(5-methoxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof Article Snippet: Erythroid Differentiation Media is comprised of IMDM (Life Technologies) supplemented with insulin (10 μg/mL, Sigma Aldrich), heparin (2 U/mL Sigma Aldrich), holo-transferrin (330 μg/mL, Sigma Aldrich), human serum AB (5%, Sigma Aldrich), hydrocortisone (1 μM, STEMCELL Technologies), Article Title: Deciphering transcriptome alterations in bone marrow hematopoiesis at single-cell resolution in immune thrombocytopenia. Article Snippet: In vitro culture CD9+Lin−CD34+CD45RA− and CD9−Lin−CD34+CD45RA− HSPCs were cultured in 96-well plates with StemSpan SFEM II medium (09655, STEMCELL Technologies, Vancouver, BC, Canada) supplemented with recombinant human stem-cell factor (rhSCF; 50 ng/mL; PeproTech, Rocky Hill, NJ, USA), Article Title: Pyrazolopyridine derivatives and uses thereof Article Snippet: In the first phase, cells were cultured in StemSpanTM Serum-Free Expansion Media (SFEM) (STEMCELL Technologies Inc.) supplemented with Article Title: Large-scale discovery of potent, compact and erythroid specific enhancers for gene therapy vectors Article Snippet: Granulocytic/monocytic differentiation of CD34 + cells was achieved by culturing the cells in the same basal medium used for the ex vivo erythroid differentiation, with a different cytokine cocktail: 50 ng/mL Article Title: Deciphering transcriptome alterations in bone marrow hematopoiesis at single-cell resolution in immune thrombocytopenia Article Snippet: CD9 + Lin − CD34 + CD45RA − and CD9 − Lin − CD34 + CD45RA − HSPCs were cultured in 96-well plates with StemSpan SFEM II medium (09655, STEMCELL Technologies, Vancouver, BC, Canada) supplemented with recombinant human stem-cell factor (rhSCF; 50 ng/mL; PeproTech, Rocky Hill, NJ, USA), Article Title: Pyrazolopyridine derivatives and uses thereof Article Snippet: In the first phase, cells were cultured in StemSpanTM Serum-Free Expansion Media (SFEM) (STEMCELL Technologies Inc.) supplemented with Article Title: A hiPSC-derived lineage-specific vascular smooth muscle cell-on-a-chip identifies aortic heterogeneity across segments. Article Snippet: Aortic aneurysm (AA), a potentially lethal condition with the characteristic of aortic dilatation, can only be treated by surgical or endovascular procedures.. The underlying mechanisms of AA are unclear and early preventive treatment is still insufficient due to segmental aortic heterogeneity and the limitations of current disease models.. Here, we firstly established a comprehensive lineage-specific vascular smooth muscle cell (SMC)-on-a-chip model using human induced pluripotent stem cells to yield cell lineages representing different segments of the aorta and tested the constructed organ-on-a-chip model under various tensile stress conditions. Article Title: 3-(5-methoxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof Article Snippet: In the first phase, cells were cultured in STEMSPANTM Serum-Free Expansion Media (SFEM) (STEMCELL Technologies Inc.) supplemented with In Vitro:Article Title: 3-(5-methoxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof Article Snippet: Erythroid Differentiation Media is comprised of IMDM (Life Technologies) supplemented with insulin (10 μg/mL, Sigma Aldrich), heparin (2 U/mL Sigma Aldrich), holo-transferrin (330 μg/mL, Sigma Aldrich), human serum AB (5%, Sigma Aldrich), hydrocortisone (1 μM, STEMCELL Technologies), Article Title: Deciphering transcriptome alterations in bone marrow hematopoiesis at single-cell resolution in immune thrombocytopenia. Article Snippet: In vitro culture CD9+Lin−CD34+CD45RA− and CD9−Lin−CD34+CD45RA− HSPCs were cultured in 96-well plates with StemSpan SFEM II medium (09655, STEMCELL Technologies, Vancouver, BC, Canada) supplemented with recombinant human stem-cell factor (rhSCF; 50 ng/mL; PeproTech, Rocky Hill, NJ, USA), Article Title: Pyrazolopyridine derivatives and uses thereof Article Snippet: In the first phase, cells were cultured in StemSpanTM Serum-Free Expansion Media (SFEM) (STEMCELL Technologies Inc.) supplemented with Article Title: Large-scale discovery of potent, compact and erythroid specific enhancers for gene therapy vectors Article Snippet: Granulocytic/monocytic differentiation of CD34 + cells was achieved by culturing the cells in the same basal medium used for the ex vivo erythroid differentiation, with a different cytokine cocktail: 50 ng/mL Article Title: Deciphering transcriptome alterations in bone marrow hematopoiesis at single-cell resolution in immune thrombocytopenia Article Snippet: CD9 + Lin − CD34 + CD45RA − and CD9 − Lin − CD34 + CD45RA − HSPCs were cultured in 96-well plates with StemSpan SFEM II medium (09655, STEMCELL Technologies, Vancouver, BC, Canada) supplemented with recombinant human stem-cell factor (rhSCF; 50 ng/mL; PeproTech, Rocky Hill, NJ, USA), Article Title: Pyrazolopyridine derivatives and uses thereof Article Snippet: In the first phase, cells were cultured in StemSpanTM Serum-Free Expansion Media (SFEM) (STEMCELL Technologies Inc.) supplemented with Article Title: A hiPSC-derived lineage-specific vascular smooth muscle cell-on-a-chip identifies aortic heterogeneity across segments. Article Snippet: Aortic aneurysm (AA), a potentially lethal condition with the characteristic of aortic dilatation, can only be treated by surgical or endovascular procedures.. The underlying mechanisms of AA are unclear and early preventive treatment is still insufficient due to segmental aortic heterogeneity and the limitations of current disease models.. Here, we firstly established a comprehensive lineage-specific vascular smooth muscle cell (SMC)-on-a-chip model using human induced pluripotent stem cells to yield cell lineages representing different segments of the aorta and tested the constructed organ-on-a-chip model under various tensile stress conditions. Article Title: 3-(5-methoxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof Article Snippet: In the first phase, cells were cultured in STEMSPANTM Serum-Free Expansion Media (SFEM) (STEMCELL Technologies Inc.) supplemented with Recombinant:Article Title: 3-(5-methoxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof Article Snippet: Erythroid Differentiation Media is comprised of IMDM (Life Technologies) supplemented with insulin (10 μg/mL, Sigma Aldrich), heparin (2 U/mL Sigma Aldrich), holo-transferrin (330 μg/mL, Sigma Aldrich), human serum AB (5%, Sigma Aldrich), hydrocortisone (1 μM, STEMCELL Technologies), Article Title: Deciphering transcriptome alterations in bone marrow hematopoiesis at single-cell resolution in immune thrombocytopenia. Article Snippet: In vitro culture CD9+Lin−CD34+CD45RA− and CD9−Lin−CD34+CD45RA− HSPCs were cultured in 96-well plates with StemSpan SFEM II medium (09655, STEMCELL Technologies, Vancouver, BC, Canada) supplemented with recombinant human stem-cell factor (rhSCF; 50 ng/mL; PeproTech, Rocky Hill, NJ, USA), Article Title: Pyrazolopyridine derivatives and uses thereof Article Snippet: In the first phase, cells were cultured in StemSpanTM Serum-Free Expansion Media (SFEM) (STEMCELL Technologies Inc.) supplemented with Article Title: Large-scale discovery of potent, compact and erythroid specific enhancers for gene therapy vectors Article Snippet: Granulocytic/monocytic differentiation of CD34 + cells was achieved by culturing the cells in the same basal medium used for the ex vivo erythroid differentiation, with a different cytokine cocktail: 50 ng/mL Article Title: Deciphering transcriptome alterations in bone marrow hematopoiesis at single-cell resolution in immune thrombocytopenia Article Snippet: CD9 + Lin − CD34 + CD45RA − and CD9 − Lin − CD34 + CD45RA − HSPCs were cultured in 96-well plates with StemSpan SFEM II medium (09655, STEMCELL Technologies, Vancouver, BC, Canada) supplemented with recombinant human stem-cell factor (rhSCF; 50 ng/mL; PeproTech, Rocky Hill, NJ, USA), Article Title: Pyrazolopyridine derivatives and uses thereof Article Snippet: In the first phase, cells were cultured in StemSpanTM Serum-Free Expansion Media (SFEM) (STEMCELL Technologies Inc.) supplemented with Article Title: A hiPSC-derived lineage-specific vascular smooth muscle cell-on-a-chip identifies aortic heterogeneity across segments. Article Snippet: Aortic aneurysm (AA), a potentially lethal condition with the characteristic of aortic dilatation, can only be treated by surgical or endovascular procedures.. The underlying mechanisms of AA are unclear and early preventive treatment is still insufficient due to segmental aortic heterogeneity and the limitations of current disease models.. Here, we firstly established a comprehensive lineage-specific vascular smooth muscle cell (SMC)-on-a-chip model using human induced pluripotent stem cells to yield cell lineages representing different segments of the aorta and tested the constructed organ-on-a-chip model under various tensile stress conditions. Article Title: 3-(5-methoxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof Article Snippet: In the first phase, cells were cultured in STEMSPANTM Serum-Free Expansion Media (SFEM) (STEMCELL Technologies Inc.) supplemented with |
